Why Earlier Palliative Care Belongs in Health Plans’ Quality Strategy
Apr 01, 2026
Health plans are under pressure to improve quality for members with serious illness while reducing emergency department visits, hospitalizations and unwanted intensive care. Earlier identification of members eligible for palliative care is emerging as one way to address both goals — but only if it is integrated before crisis points.
A small group of members with advanced or complex illness often account for a disproportionate share of utilization and cost, but cost is only part of the issue. These members often move among specialists and care settings as symptoms change.
When care is reactive, the system defaults to escalation: symptom flares become emergency visits, medication complexity contributes to deterioration, and unclear goals leave families and clinicians making choices in crisis. High-intensity interventions may occur not because they reflect member preferences, but because support, planning, and alignment came too late. Physician-led palliative care should be viewed as a quality strategy for high-risk serious-illness populations.
What is physician-led palliative care, and how is it different from hospice?
Palliative care is often mistaken for hospice or end-of-life care. It is not. It is non-hospice specialty medical care for people living with serious illness at any stage, and it can be delivered alongside curative or disease-directed treatment before a terminal prognosis or hospice election is appropriate.
When palliative care is introduced only at the end of life, the work becomes crisis management. When introduced earlier, it can stabilize symptoms, clarify goals, coordinate providers, and support caregivers so members have a trusted team to call before an avoidable crisis determines the next care setting.
Goal-aligned serious-illness care is a measurable quality issue
In serious illness, quality depends on whether decisions reflect prognosis, treatment options, function, symptoms, caregiver context, and personal goals. Without structured support, families may make complex choices without understanding benefits, burdens, or alternatives. In that gap, high-intensity care can become the default, even when it is not beneficial or desired.
With the Carelon Palliative Care program, advance care planning discussions are completed for 93% of eligible members and families, compared with an approximately 50% national benchmark1. For clinical leaders, that metric signals whether members are having timely conversations that can inform treatment choices, reduce ICU and end-of-life interventions, and support meaningful decisions. A serious-illness care plan that doesn’t incorporate the member's goals is incomplete. Unmanaged symptoms, fragmented communication, and uncertainty about preferences create a quality gap and increase the likelihood of acute care utilization.
How physician-led palliative care improves serious-illness decision-making
Outreach alone cannot address many serious-illness needs. Members may require medication review and prescribing, symptom management, urgent triage, prognosis discussions, or coordination among providers who see only part of the clinical picture.
A physician-led palliative care model brings those capabilities together. Carelon offers physicians, advanced practice providers, social workers, care support specialists, and behavioral health resources. The team supports symptom and disease management, medication review, advance care planning, caregiver education, care coordination, and 24/7/365 clinician access for urgent issues and triage.
That structure matters because escalation often happens between visits. With physician-led support and always-on access, the team can intervene earlier, adjust the plan, coordinate with treating clinicians, and help the member receive care in the right setting.
Reducing avoidable utilization through earlier palliative care
Utilization reduction in serious-illness care should not mean reducing necessary treatment or delaying appropriate hospitalization. The goal is to avoid escalation that is preventable, misaligned with member goals, or driven by support gaps. That means identifying high-risk members earlier, stabilizing symptoms, reviewing medications, providing after-hours access, coordinating with PCPs, specialists, and care managers, and documenting goals before pressure mounts.
Carelon connects these clinical levers to measurable outcomes, including up to 2.1 to 5.5:1 return on investment2, 79 NPS (Net Promoter Score)3, and a 56% reduction in hospital admissions for a Medicare end-of-life group in an internal study.4 Outcomes will vary, but proactive, physician-led support can help serious-illness care become more stable and aligned with member priorities.
What can we help you solve?
Every organization faces different challenges. Tell us what you’re working to solve, and we’ll bring together the right clinical expertise, data, technology, and capabilities to support your goals.